Mitazalimab
![Combining mitazalimab with chemotherapy demonstrates significant antitumor activity in metastatic pancreatic ductal adenocarcinoma _ Pharmtales - Latest Pharma News & Insights](https://pharmtales.com/wp-content/uploads/2023/06/Combining-mitazalimab-with-chemotherapy-demonstrates-significant-antitumor-activity-in-metastatic-pancreatic-ductal-adenocarcinoma-_-Pharmtales-Latest-Pharma-News-Insights.jpg)
Combining mitazalimab with chemotherapy demonstrates significant antitumor activity in metastatic pancreatic ductal adenocarcinoma
SG Tylor
Source – Alligator Bioscience On June 26, 2023 the combination of mitazalimab, a novel CD40 monoclonal antibody agonist, with chemotherapy ...